{
  "id": "prt_95bb923b4001FqOYtyb2w7EqZZ",
  "messageID": "msg_95bb8eea00015VPcC5p9K9K2k2",
  "sessionID": "ses_6a7af0913ffePKeafEVjU8Zw0Y",
  "type": "tool",
  "tool": "read",
  "callID": "toolu_015keXfxGpZQC4NY78Ps33vd",
  "state": {
    "status": "completed",
    "input": {
      "filePath": "/home/user/project/lib/translations/en.ts"
    },
    "output": "<file>\n00001| import { Translation } from './types'\n00002| \n00003| export const en: Translation = {\n00004|   app: {\n00005|     title: 'VisibleDx: ME/CFS · Long COVID · POTS',\n00006|     subtitle: 'An educational training tool for learning evidence-based criteria for ME/CFS, Long COVID, and POTS. For healthcare education and training purposes only.',\n00007|     tagline: 'Making invisible diseases visible - with evidence, empathy and code.',\n00008|     backToDashboard: 'Back to Dashboard'\n00009|   },\n00010| \n00011|   common: {\n00012|     yes: 'Yes',\n00013|     no: 'No',\n00014|     next: 'Next',\n00015|     previous: 'Previous',\n00016|     continue: 'Continue',\n00017|     complete: 'Complete',\n00018|     cancel: 'Cancel',\n00019|     save: 'Save',\n00020|     download: 'Download',\n00021|     loading: 'Loading',\n00022|     processing: 'Processing',\n00023|     error: 'Error',\n00024|     success: 'Success',\n00025|     retry: 'Retry',\n00026|     close: 'Close',\n00027|     step: 'Step',\n00028|     of: 'of',\n00029|     progress: 'Progress',\n00030|     completing: 'Completing',\n00031|     saving: 'Saving',\n00032|     back: 'Back',\n00033|     goBack: 'Go Back',\n00034|     exit: 'Exit',\n00035|     restart: 'Restart',\n00036|     reset: 'Reset',\n00037|     confirm: 'Confirm',\n00038|     areYouSure: 'Are you sure?',\n00039|     age: 'Age',\n00040|     gender: 'Gender',\n00041|     male: 'Male',\n00042|     female: 'Female',\n00043|     other: 'Other',\n00044|     question: 'Question',\n00045|     minute: 'minute',\n00046|     minutes: 'minutes',\n00047|     bpm: 'bpm',\n00048|     criteria: 'Criteria',\n00049|     met: 'Met',\n00050|     notMet: 'Not Met',\n00051|     high: 'High',\n00052|     medium: 'Medium',\n00053|     low: 'Low',\n00054|     none: 'None',\n00055|     mild: 'Mild',\n00056|     moderate: 'Moderate',\n00057|     severe: 'Severe',\n00058|     confidence: 'Confidence',\n00059|     sensitivity: 'Sensitivity',\n00060|     score: 'Score',\n00061|     results: 'Results',\n00062|     recommendations: 'Recommendations',\n00063|     clinician: 'Clinician',\n00064|     patientId: 'Patient ID',\n00065|     required: 'Required',\n00066|     optional: 'Optional'\n00067|   },\n00068| \n00069|   dashboard: {\n00070|     smartAssessment: {\n00071|       title: 'Educational Training Simulation',\n00072|       description: 'Interactive learning workflow with educational documentation examples',\n00073|       autoRouting: 'Auto-routing',\n00074|       soapNotes: 'SOAP notes',\n00075|       icdCodes: 'ICD-10 codes',\n00076|       startNew: 'Start Training Session'\n00077|     },\n00078|     modules: {\n00079|       quickScreen: {\n00080|         title: 'Initial Screening',\n00081|         description: 'Chief complaint & symptom review (16 questions, ~2 min)'\n00082|       },\n00083|       redFlag: {\n00084|         title: 'Differential Diagnosis',\n00085|         description: 'Rule out alternative diagnoses & red flag symptoms'\n00086|       },\n00087|       standTest: {\n00088|         title: 'Orthostatic Vitals',\n00089|         description: 'Standing test with heart rate monitoring (NASA protocol)'\n00090|       },\n00091|       pemQuest: {\n00092|         title: 'PEM Assessment',\n00093|         description: 'Post-exertional malaise symptom evaluation'\n00094|       },\n00095|       criteriaEngine: {\n00096|         title: 'Diagnostic Criteria',\n00097|         description: 'Apply clinical criteria (CDC, WHO, ESC guidelines)'\n00098|       },\n00099|       subtypeAdvisor: {\n00100|         title: 'Clinical Management',\n00101|         description: 'Condition subtyping & treatment planning examples'\n00102|       }\n00103|     },\n00104|     stats: {\n00105|       diagnosticDelay: '4-5 year avg diagnostic delay',\n00106|       doctorsConsulted: '≥7 doctors typically consulted',\n00107|       sensitivityValidated: '94% sensitivity validated'\n00108|     },\n00109|     algorithm: {\n00110|       title: 'Educational Algorithm',\n00111|       mecfs: {\n00112|         title: 'ME/CFS',\n00113|         criteria: 'CDC/NASEM 2015 + IOM criteria',\n00114|         description: '3 core + 1 PEM symptom cluster'\n00115|       },\n00116|       longCovid: {\n00117|         title: 'Long COVID',\n00118|         criteria: 'WHO + NASEM 2024 criteria',\n00119|         description: '≥3 months post-SARS-CoV-2'\n00120|       },\n00121|       pots: {\n00122|         title: 'POTS',\n00123|         criteria: 'ESC 2018 + AAS/EFAS 2021',\n00124|         description: 'HR↑≥30 bpm within 10 min'\n00125|       }\n00126|     },\n00127|     startAssessment: 'Start Assessment'\n00128|   },\n00129| \n00130|   quickScreen: {\n00131|     title: 'Quick-Screen Training',\n00132|     description: '16 questions · ~2 minutes · 92% sensitivity',\n00133|     questions: [\n00134|       'Do you experience severe fatigue that is not relieved by rest?',\n00135|       'Does physical or mental activity make your symptoms worse (Post-Exertional Malaise)?',\n00136|       'Do you have unrefreshing sleep, regardless of duration?',\n00137|       'Do you experience cognitive difficulties (brain fog, memory problems)?',\n00138|       'Do you have palpitations or rapid heart rate, especially when standing?',\n00139|       'Do you experience dizziness or lightheadedness when standing up?',\n00140|       'Have you had COVID-19 or suspected COVID-19 infection?',\n00141|       'Have your symptoms persisted for 3 months or longer?',\n00142|       'Do you experience muscle pain or joint pain without swelling?',\n00143|       'Do you have frequent headaches or changes in headache patterns?',\n00144|       'Do you experience temperature dysregulation (feeling too hot/cold)?',\n00145|       'Do you have gastrointestinal symptoms (nausea, bloating, changes in bowel habits)?',\n00146|       'Do you experience shortness of breath or breathing difficulties?',\n00147|       'Have you noticed decreased exercise tolerance or physical capacity?',\n00148|       'Do you experience sensitivity to light, sound, or touch?',\n00149|       'Have you been unable to maintain your previous level of activity?'\n00150|     ],\n00151|     categories: {\n00152|       core: 'Core',\n00153|       pem: 'PEM',\n00154|       cardiovascular: 'Cardiovascular',\n00155|       orthostatic: 'Orthostatic',\n00156|       history: 'History',\n00157|       duration: 'Duration',\n00158|       pain: 'Pain',\n00159|       neurological: 'Neurological',\n00160|       autonomic: 'Autonomic',\n00161|       gi: 'GI',\n00162|       respiratory: 'Respiratory',\n00163|       functional: 'Functional',\n00164|       sensory: 'Sensory'\n00165|     },\n00166|     results: {\n00167|       complete: 'Screening Complete',\n00168|       riskAssessment: 'Educational simulation - Based on your responses, here\\'s the training scenario',\n00169|       lowRisk: 'Low Risk for ME/CFS, Long COVID, or POTS',\n00170|       mediumRisk: 'Medium Risk for ME/CFS, Long COVID, or POTS',\n00171|       highRisk: 'High Risk for ME/CFS, Long COVID, or POTS',\n00172|       totalResponses: 'Total positive responses',\n00173|       coreSymptoms: 'Core symptoms present',\n00174|       pemPresent: 'Post-exertional malaise',\n00175|       covidHistory: 'COVID history',\n00176|       chronicSymptoms: 'Chronic symptoms (≥3 months)',\n00177|       nextSteps: 'Next Steps',\n00178|       retake: 'Retake Screening'\n00179|     },\n00180|     nextStepsRecommendations: {\n00181|       high: [\n00182|         'Proceed to Red-flag Checker',\n00183|         'Complete Stand-Test Pro',\n00184|         'Consider PEM-Quest assessment'\n00185|       ],\n00186|       medium: [\n00187|         'Consider Red-flag Checker',\n00188|         'Monitor symptoms closely',\n00189|         'Follow-up in 4-6 weeks'\n00190|       ],\n00191|       low: [\n00192|         'Routine clinical assessment',\n00193|         'Consider other diagnoses',\n00194|         'Reassess if symptoms worsen'\n00195|       ]\n00196|     }\n00197|   },\n00198| \n00199|   redFlag: {\n00200|     title: 'Red-flag Checker',\n00201|     description: 'Identify symptoms requiring urgent evaluation and rule out explanatory diseases',\n00202|     symptoms: {\n00203|       title: 'Red Flag Symptoms',\n00204|       description: 'Check any symptoms present that may require urgent evaluation',\n00205|       list: [\n00206|         'Persistent fever or night sweats',\n00207|         'Unintentional weight loss >10% in 6 months',\n00208|         'Chest pain with exertion or at rest',\n00209|         'Progressive shortness of breath',\n00210|         'New neurological symptoms (weakness, numbness, seizures)',\n00211|         'Abnormal bleeding or bruising',\n00212|         'Enlarged lymph nodes',\n00213|         'Jaundice or yellowing of skin/eyes'\n00214|       ]\n00215|     },\n00216|     urgentCategories: [\n00217|       'Infectious/Inflammatory',\n00218|       'Malignancy/Metabolic', \n00219|       'Cardiovascular',\n00220|       'Cardiopulmonary',\n00221|       'Neurological',\n00222|       'Hematological',\n00223|       'Infectious/Malignancy',\n00224|       'Hepatic'\n00225|     ],\n00226|     routineLabs: {\n00227|       title: 'Routine Screening Labs',\n00228|       description: 'Select categories of tests to rule out common explanatory conditions',\n00229|       categories: {\n00230|         basicMetabolic: {\n00231|           title: 'Basic Metabolic',\n00232|           indication: 'Rule out anemia, infection, inflammation, electrolyte abnormalities',\n00233|           tests: ['CBC with differential', 'Comprehensive metabolic panel', 'ESR', 'CRP']\n00234|         },\n00235|         endocrine: {\n00236|           title: 'Endocrine',\n00237|           indication: 'Rule out thyroid dysfunction, diabetes, adrenal insufficiency',\n00238|           tests: ['TSH', 'Free T4', 'HbA1c', 'Cortisol (AM)', 'Vitamin D']\n00239|         },\n00240|         nutritional: {\n00241|           title: 'Nutritional',\n00242|           indication: 'Rule out nutritional deficiencies causing fatigue',\n00243|           tests: ['Vitamin B12', 'Folate', 'Iron studies', 'Ferritin']\n00244|         },\n00245|         autoimmune: {\n00246|           title: 'Autoimmune',\n00247|           indication: 'Screen for autoimmune conditions',\n00248|           tests: ['ANA', 'RF', 'Anti-CCP', 'Celiac antibodies']\n00249|         },\n00250|         cardiac: {\n00251|           title: 'Cardiac',\n00252|           indication: 'Rule out structural heart disease, heart failure',\n00253|           tests: ['ECG', 'Echocardiogram', 'BNP/NT-proBNP']\n00254|         },\n00255|         infectious: {\n00256|           title: 'Infectious',\n00257|           indication: 'Rule out chronic infections',\n00258|           tests: ['Hepatitis B/C', 'HIV', 'Lyme antibodies', 'CMV/EBV antibodies']\n00259|         }\n00260|       }\n00261|     },\n00262|     results: {\n00263|       complete: 'Red-flag Assessment Complete',\n00264|       urgentEval: 'Urgent Evaluation Required',\n00265|       priorityTests: 'Priority Tests (Red Flags)',\n00266|       routineTests: 'Routine Screening Tests',\n00267|       noRedFlags: 'No Red Flags Identified',\n00268|       clinicalSupport: 'Clinical Decision Support',\n00269|       urgent: 'Expedite workup due to high-priority red flags. Consider same-day or next-day evaluation. Hold off on ME/CFS/POTS assessment until red flags ruled out.',\n00270|       priority: 'Complete recommended tests within 1-2 weeks. Can proceed with stand-test if cardiovascular red flags absent. Re-evaluate based on test results.',\n00271|       routine: 'Proceed with routine screening labs. Can continue with ME/CFS/Long COVID/POTS assessment. Consider 4-6 week follow-up for test results.',\n00272|       reassess: 'Reassess',\n00273|       generateRecommendations: 'Generate Recommendations'\n00274|     }\n00275|   },\n00276| \n00277|   standTest: {\n00278|     title: 'Stand-Test Pro',\n00279|     description: 'NASA Lean Stand Test Protocol - 10 minute heart rate monitoring',\n00280|     setup: {\n00281|       title: 'Test Setup',\n00282|       description: 'Choose your preferred method for heart rate monitoring',\n00283|       manual: {\n00284|         title: 'Manual Entry',\n00285|         description: 'Use pulse oximeter, fitness tracker, or manual pulse counting',\n00286|         recommended: 'Recommended'\n00287|       },\n00288|       camera: {\n00289|         title: 'Camera PPG',\n00290|         description: 'Use device camera for photoplethysmography (experimental)',\n00291|         beta: 'Beta Feature'\n00292|       },\n00293|       safety: 'Safety Note: Stop the test immediately if you experience chest pain, severe dizziness, or feel faint. Have a chair nearby for safety.',\n00294|       startTest: 'Start Stand Test'\n00295|     },\n00296|     phases: {\n00297|       baseline: {\n00298|         name: 'Baseline Lying',\n00299|         instructions: 'Lie down comfortably and remain still. Breathe normally and relax.'\n00300|       },\n00301|       standing: {\n00302|         name: 'Standing Phase',\n00303|         instructions: 'Stand up quickly and remain standing. Do not lean against walls or move around.'\n00304|       }\n00305|     },\n00306|     recording: {\n00307|       title: 'Record Heart Rate',\n00308|       description: 'Enter current heart rate reading (record every 1-2 minutes)',\n00309|       baselineHR: 'Baseline HR (lying down)',\n00310|       peakHR: 'Peak Standing HR',\n00311|       systolicBP: 'Systolic BP (optional)',\n00312|       diastolicBP: 'Diastolic BP (optional)',\n00313|       recordReading: 'Record Reading',\n00314|       recentReadings: 'Recent Readings'\n00315|     },\n00316|     results: {\n00317|       title: 'Stand-Test Results',\n00318|       description: 'NASA Lean Stand Test Results - 10 minute protocol',\n00319|       baseline: 'Baseline (Lying)',\n00320|       peakStanding: 'Peak Standing',\n00321|       sustainedStanding: 'Sustained Standing',\n00322|       averageHR: 'Average heart rate',\n00323|       maxHR: 'Maximum heart rate',\n00324|       hrIncrease: 'HR Increase',\n00325|       potsCriteria: 'POTS Criteria',\n00326|       potsMet: 'POTS Criteria Met',\n00327|       potsNotMet: 'POTS Criteria Not Met',\n00328|       interpretation: 'Clinical Interpretation',\n00329|       nextSteps: 'Next Steps',\n00330|       repeatTest: 'Repeat Test'\n00331|     },\n00332|     interpretations: {\n00333|       potsMet: [\n00334|         'Heart rate increase suggests orthostatic intolerance consistent with POTS',\n00335|         'Proceed to POTS subtyping for targeted treatment recommendations',\n00336|         'Consider additional autonomic testing if clinically indicated',\n00337|         'Rule out secondary causes (dehydration, medications, other conditions)'\n00338|       ],\n00339|       potsNotMet: [\n00340|         'Normal orthostatic heart rate response',\n00341|         'POTS unlikely based on current criteria',\n00342|         'Consider other causes of symptoms (ME/CFS, Long COVID without POTS)',\n00343|         'Repeat testing if symptoms persist or worsen'\n00344|       ]\n00345|     },\n00346|     controls: {\n00347|       pause: 'Pause',\n00348|       resume: 'Resume',\n00349|       stop: 'Stop Test'\n00350|     }\n00351|   },\n00352| \n00353|   pem: {\n00354|     title: 'PEM-Quest Assessment',\n00355|     description: 'Post-Exertional Malaise evaluation - 5 validated questions',\n00356|     about: {\n00357|       title: 'About Post-Exertional Malaise (PEM)',\n00358|       description: 'PEM is the worsening of symptoms following physical or mental activity that was previously tolerated. It\\'s a key feature of ME/CFS and often occurs in Long COVID. Symptoms may be delayed and can last days to weeks.'\n00359|     },\n00360|     questions: {\n00361|       frequency: {\n00362|         question: 'How often do you experience a worsening of symptoms following physical activity?',\n00363|         description: 'Consider activities like walking, climbing stairs, or household chores',\n00364|         options: [\n00365|           'Never',\n00366|           'Rarely (less than 25% of the time)',\n00367|           'Sometimes (25-50% of the time)',\n00368|           'Often (50-75% of the time)',\n00369|           'Always or almost always (more than 75% of the time)'\n00370|         ]\n00371|       },\n00372|       mentalFrequency: {\n00373|         question: 'How often do you experience a worsening of symptoms following mental activity?',\n00374|         description: 'Consider activities like reading, concentrating, or problem-solving',\n00375|         options: [\n00376|           'Never',\n00377|           'Rarely (less than 25% of the time)',\n00378|           'Sometimes (25-50% of the time)',\n00379|           'Often (50-75% of the time)',\n00380|           'Always or almost always (more than 75% of the time)'\n00381|         ]\n00382|       },\n00383|       onsetTime: {\n00384|         question: 'How soon after activity do your symptoms typically worsen?',\n00385|         options: [\n00386|           'No worsening occurs',\n00387|           'During the activity',\n00388|           'Immediately after (within 30 minutes)',\n00389|           'Within a few hours (2-6 hours)',\n00390|           'The next day or later'\n00391|         ]\n00392|       },\n00393|       severity: {\n00394|         question: 'How severe is the worsening of your symptoms after activity?',\n00395|         options: [\n00396|           'No worsening',\n00397|           'Mild - slightly worse than before activity',\n00398|           'Moderate - noticeably worse, but manageable',\n00399|           'Severe - significantly worse, difficult to function',\n00400|           'Very severe - unable to function, bedridden'\n00401|         ]\n00402|       },\n00403|       recoveryTime: {\n00404|         question: 'How long does it typically take for your symptoms to return to baseline after activity?',\n00405|         options: [\n00406|           'No recovery time needed',\n00407|           'A few hours',\n00408|           'About one day',\n00409|           'Several days (2-6 days)',\n00410|           'A week or more'\n00411|         ]\n00412|       }\n00413|     },\n00414|     results: {\n00415|       complete: 'PEM Assessment Complete',\n00416|       description: 'Post-Exertional Malaise evaluation based on DePaul criteria',\n00417|       status: 'PEM Status',\n00418|       present: 'Post-Exertional Malaise is likely present',\n00419|       absent: 'Post-Exertional Malaise is unlikely',\n00420|       severityLevels: {\n00421|         none: 'None',\n00422|         mild: 'Mild PEM',\n00423|         moderate: 'Moderate PEM',\n00424|         severe: 'Severe PEM'\n00425|       },\n00426|       clinicalInterpretation: 'Clinical Interpretation',\n00427|       recommendations: {\n00428|         severe: [\n00429|           'Strict activity pacing essential',\n00430|           'Consider disability evaluation',\n00431|           'Specialist ME/CFS clinic referral'\n00432|         ],\n00433|         moderate: [\n00434|           'Implement careful activity pacing',\n00435|           'Monitor for symptom progression',\n00436|           'Consider occupational therapy'\n00437|         ],\n00438|         mild: [\n00439|           'Begin gentle activity pacing',\n00440|           'Education on PEM recognition',\n00441|           'Regular symptom monitoring'\n00442|         ],\n00443|         none: [\n00444|           'PEM not significantly present',\n00445|           'Consider other diagnoses',\n00446|           'Standard activity as tolerated'\n00447|         ]\n00448|       },\n00449|       important: 'Important: PEM is the hallmark symptom of ME/CFS. If present, avoid activities that consistently trigger symptom worsening. Energy management and pacing are key treatment strategies.',\n00450|       retake: 'Retake Assessment'\n00451|     }\n00452|   },\n00453| \n00454|   criteria: {\n00455|     title: 'Criteria Engine',\n00456|     description: 'Apply CDC, NASEM, ESC, WHO diagnostic criteria for final determination',\n00457|     mecfs: {\n00458|       title: 'ME/CFS Criteria (CDC/NASEM 2015)',\n00459|       description: 'Requires substantial fatigue, PEM, unrefreshing sleep, AND either cognitive impairment OR orthostatic intolerance',\n00460|       criteria: [\n00461|         'Substantial reduction or impairment in activity levels that persists for ≥6 months',\n00462|         'Post-exertional malaise (PEM) present',\n00463|         'Unrefreshing sleep',\n00464|         'Cognitive impairment (brain fog)',\n00465|         'Orthostatic intolerance OR autonomic dysfunction'\n00466|       ]\n00467|     },\n00468|     longCovid: {\n00469|       title: 'Long COVID Criteria (WHO/NASEM 2024)',\n00470|       description: 'Post-acute sequelae of SARS-CoV-2 infection with persistent multi-system symptoms',\n00471|       criteria: [\n00472|         'Confirmed or probable SARS-CoV-2 infection',\n00473|         'Symptoms persist ≥3 months from acute illness',\n00474|         'Multi-system symptoms affecting daily functioning',\n00475|         'Symptoms not explained by alternative diagnosis'\n00476|       ],\n00477|       timing: {\n00478|         confirmed: 'Confirmed by test',\n00479|         probable: 'Probable based on symptoms/exposure',\n00480|         suspected: 'Suspected based on timing'\n00481|       }\n00482|     },\n00483|     pots: {\n00484|       title: 'POTS Criteria (ESC 2018/AAS-EFAS 2021)',\n00485|       description: 'Heart rate increase ≥30 bpm within 10 minutes of standing, with symptoms but without orthostatic hypotension',\n00486|       criteria: [\n00487|         'Heart rate increase ≥30 bpm within 10 minutes of standing',\n00488|         'Sustained heart rate ≥120 bpm while standing',\n00489|         'Orthostatic symptoms (dizziness, palpitations, fatigue)',\n00490|         'Symptoms present for ≥3 months',\n00491|         'Absence of orthostatic hypotension'\n00492|       ]\n00493|     },\n00494|     results: {\n00495|       complete: 'Diagnostic Criteria Assessment Complete',\n00496|       description: 'Based on CDC, NASEM, ESC, WHO guidelines',\n00497|       diagnosesMet: 'Diagnoses Meeting Criteria',\n00498|       criteriaMet: 'CRITERIA MET',\n00499|       clinicalRecommendations: 'Clinical Recommendations',\n00500|       mecfsManagement: [\n00501|         'Implement activity pacing and energy management',\n00502|         'Avoid graded exercise therapy (GET)',\n00503|         'Consider symptom-directed treatments',\n00504|         'Specialist ME/CFS clinic referral if available'\n00505|       ],\n00506|       longCovidManagement: [\n00507|         'Multidisciplinary approach to symptom management',\n00508|         'Long COVID clinic referral if available',\n00509|         'Monitor for improvement over time',\n00510|         'Address individual symptoms (fatigue, cognitive, respiratory)'\n00511|       ],\n00512|       potsManagement: [\n00513|         'Proceed to subtype determination for targeted therapy',\n00514|         'Non-pharmacological: salt, fluids, compression garments',\n00515|         'Consider cardiology or autonomic specialist referral',\n00516|         'Gradual exercise reconditioning when appropriate'\n00517|       ],\n00518|       reassess: 'Reassess Criteria',\n00519|       downloadReport: 'Download Report',\n00520|       potsSubtype: 'POTS Subtype Analysis'\n00521|     }\n00522|   },\n00523| \n00524|   subtype: {\n00525|     title: 'POTS Subtype & Treatment Advisor',\n00526|     description: 'Determine POTS subtype for personalized treatment recommendations',\n00527|     patientInfo: {\n00528|       title: 'Patient Information',\n00529|       description: 'Basic patient details for treatment planning',\n00530|       comorbidities: 'Relevant Comorbidities (check all that apply)',\n00531|       comorbidityOptions: ['Diabetes', 'Autoimmune Disease', 'EDS', 'MCAS']\n00532|     },\n00533|     subtypes: {\n00534|       hypovolemic: {\n00535|         name: 'Hypovolemic POTS',\n00536|         description: 'Low blood volume causing orthostatic intolerance',\n00537|         criteria: [\n00538|           'Low-normal blood pressure (<110/70)',\n00539|           'Excessive thirst',\n00540|           'Salt craving',\n00541|           'Signs of volume depletion',\n00542|           'Elevated renin/aldosterone (if available)'\n00543|         ],\n00544|         treatments: {\n00545|           nonPharmacological: [\n00546|             'Increase fluid intake to 2.5-3L daily',\n00547|             'Increase sodium intake to 8-10g daily',\n00548|             'Compression garments (30-40 mmHg)',\n00549|             'Gradual exercise reconditioning'\n00550|           ],\n00551|           firstLine: [\n00552|             'Fludrocortisone 0.1-0.2mg daily',\n00553|             'Salt tablets if dietary intake insufficient'\n00554|           ],\n00555|           secondLine: [\n00556|             'Desmopressin (DDAVP) for severe cases',\n00557|             'Erythropoietin if anemic'\n00558|           ]\n00559|         }\n00560|       },\n00561|       neuropathic: {\n00562|         name: 'Neuropathic POTS',\n00563|         description: 'Peripheral autonomic neuropathy affecting blood vessel control',\n00564|         criteria: [\n00565|           'Distal small fiber neuropathy symptoms',\n00566|           'GI dysfunction (gastroparesis, constipation)',\n00567|           'Anhidrosis or reduced sweating',\n00568|           'Pupillary abnormalities',\n00569|           'History of diabetes or autoimmune disease'\n00570|         ],\n00571|         treatments: {\n00572|           nonPharmacological: [\n00573|             'Compression garments',\n00574|             'Leg elevation',\n00575|             'Avoid heat exposure',\n00576|             'Small frequent meals'\n00577|           ],\n00578|           firstLine: [\n00579|             'Midodrine 2.5-10mg TID',\n00580|             'Pyridostigmine 30-60mg TID'\n00581|           ],\n00582|           secondLine: [\n00583|             'Droxidopa (if available)',\n00584|             'Alpha-lipoic acid for neuropathy',\n00585|             'IVIG for autoimmune cases'\n00586|           ]\n00587|         }\n00588|       },\n00589|       hyperadrenergic: {\n00590|         name: 'Hyperadrenergic POTS',\n00591|         description: 'Excessive sympathetic nervous system activation',\n00592|         criteria: [\n00593|           'Hypertension when standing',\n00594|           'Anxiety, panic attacks, tremor',\n00595|           'Migraine headaches',\n00596|           'Cold hands and feet',\n00597|           'Elevated standing norepinephrine >600 pg/mL'\n00598|         ],\n00599|         treatments: {\n00600|           nonPharmacological: [\n00601|             'Stress reduction techniques',\n00602|             'Avoid stimulants (caffeine)',\n00603|             'Regular sleep schedule',\n00604|             'Gentle exercise'\n00605|           ],\n00606|           firstLine: [\n00607|             'Propranolol 10-20mg BID-QID',\n00608|             'Clonidine 0.1-0.2mg BID'\n00609|           ],\n00610|           secondLine: [\n00611|             'Ivabradine 2.5-7.5mg BID',\n00612|             'Methyldopa',\n00613|             'Labetalol for hypertension'\n00614|           ]\n00615|         }\n00616|       },\n00617|       autoimmune: {\n00618|         name: 'Autoimmune POTS',\n00619|         description: 'Autoimmune-mediated autonomic dysfunction',\n00620|         criteria: [\n00621|           'Personal/family history of autoimmune disease',\n00622|           'Rapid onset of symptoms',\n00623|           'Viral illness trigger (EBV, COVID, etc.)',\n00624|           'Positive autonomic antibodies (if tested)',\n00625|           'Other autoimmune markers positive'\n00626|         ],\n00627|         treatments: {\n00628|           nonPharmacological: [\n00629|             'Standard POTS measures',\n00630|             'Avoid infection triggers',\n00631|             'Stress management',\n00632|             'Anti-inflammatory diet'\n00633|           ],\n00634|           firstLine: [\n00635|             'Standard POTS medications',\n00636|             'Trial of corticosteroids'\n00637|           ],\n00638|           secondLine: [\n00639|             'IVIG therapy',\n00640|             'Immunosuppressive agents',\n00641|             'Plasmapheresis for severe cases'\n00642|           ]\n00643|         }\n00644|       }\n00645|     },\n00646|     results: {\n00647|       complete: 'POTS Subtype Analysis Complete',\n00648|       description: 'Personalized treatment recommendations based on subtype assessment',\n00649|       primary: 'Primary',\n00650|       likelihood: 'likelihood',\n00651|       criteriaMetTitle: 'Criteria Met',\n00652|       allSubtypeScores: 'All Subtype Scores',\n00653|       nonPharmacological: 'Non-Pharmacological',\n00654|       firstLineRx: 'First-Line Rx',\n00655|       secondLineOptions: 'Second-Line Options',\n00656|       mixedSubtype: 'Mixed Subtype Considerations: This patient also shows features of multiple subtypes. Consider combination therapy approaches and monitor response to initial treatment.',\n00657|       clinicalPearls: 'Clinical Pearls',\n00658|       pearls: [\n00659|         'Start with non-pharmacological interventions for all POTS subtypes',\n00660|         'Begin medications at low doses and titrate slowly',\n00661|         'Monitor response and adjust treatment based on symptom improvement',\n00662|         'Consider specialist referral for complex cases or treatment failures',\n00663|         'Re-assess subtype if treatment response is poor'\n00664|       ],\n00665|       reassess: 'Reassess Subtype',\n00666|       downloadPlan: 'Download Treatment Plan',\n00667|       analysisHeader: 'SUBTYPE ANALYSIS',\n00668|       secondaryConsiderations: 'Secondary considerations',\n00669|       and: ' and '\n00670|     }\n00671|   },\n00672| \n00673|   newPatient: {\n00674|     title: 'New Patient Assessment',\n00675|     description: 'Intelligent guided evaluation for ME/CFS, Long COVID, and POTS',\n00676|     demographics: {\n00677|       title: 'Patient Information',\n00678|       description: 'Basic demographics for clinical documentation',\n00679|       step: 'Step 1 of 7: Patient Demographics',\n00680|       age: 'Patient Age',\n00681|       gender: 'Gender',\n00682|       clinicianName: 'Clinician Name',\n00683|       patientId: 'Patient ID/MRN',\n00684|     startAssessment: 'Start Training'\n00685|     },\n00686|     progress: {\n00687|       step1: 'Demographics',\n00688|       step2: 'Quick Screen',\n00689|       step3: 'Red Flags',\n00690|       step4: 'Stand Test',\n00691|       step5: 'PEM Quest',\n00692|       step6: 'Criteria',\n00693|       step7: 'Summary'\n00694|     },\n00695|     redFlags: {\n00696|       title: 'Red Flag Assessment',\n00697|       description: 'Check for symptoms requiring urgent evaluation',\n00698|       selectSymptoms: 'Select any symptoms present',\n00699|       continueAssessment: 'Continue Assessment'\n00700|     },\n00701|     standTest: {\n00702|       title: 'Orthostatic Assessment',\n00703|       description: 'Record baseline and standing heart rates',\n00704|       measurements: 'Heart Rate Measurements',\n00705|       measurementDescription: 'Enter heart rate after 5 minutes lying down and peak heart rate within 10 minutes of standing',\n00706|       baselineHR: 'Baseline HR (lying down)',\n00707|       peakHR: 'Peak Standing HR',\n00708|       hrIncrease: 'HR Increase',\n00709|       potsCriteria: 'POTS Criteria (≥30 bpm)',\n00710|       continueToPEM: 'Continue to PEM Assessment'\n00711|     },\n00712|     pemAssessment: {\n00713|       title: 'PEM Assessment',\n00714|       description: 'Post-Exertional Malaise evaluation',\n00715|       finalizeAssessment: 'Finalize Assessment'\n00716|     },\n00717|     processing: {\n00718|       title: 'Processing Diagnostic Criteria...',\n00719|       description: 'Analyzing responses against CDC, NASEM, ESC, and WHO guidelines'\n00720|     },\n00721|     results: {\n00722|       title: 'Patient Assessment Complete',\n00723|       description: 'Comprehensive clinical evaluation with SOAP documentation',\n00724|       primary: 'Primary',\n00725|       noDefinitiveDiagnoses: 'No Definitive Diagnoses: Consider alternative diagnoses, subclinical presentations, or ongoing symptom monitoring. Some patients may benefit from symptomatic treatment while monitoring for progression.',\n00726|       keyResults: 'Key Assessment Results',\n00727|       riskLevel: 'Risk Level',\n00728|       screeningScore: 'Screening Score',\n00729|       pemPresent: 'PEM Present',\n00730|       potsCriteria: 'POTS Criteria',\n00731|       redFlags: 'Red Flags',\n00732|       priority: 'Priority',\n00733|       newAssessment: 'New Assessment',\n00734|       downloadSOAP: 'Download SOAP Note'\n00735|     }\n00736|   },\n00737| \n00738|   conditions: {\n00739|     mecfs: {\n00740|       name: 'ME/CFS',\n00741|       fullName: 'Myalgic Encephalomyelitis/Chronic Fatigue Syndrome',\n00742|       icdCode: 'G93.32',\n00743|       criteria: [\n00744|         'Substantial fatigue not relieved by rest',\n00745|         'Post-exertional malaise',\n00746|         'Unrefreshing sleep',\n00747|         'Cognitive impairment or orthostatic intolerance'\n00748|       ]\n00749|     },\n00750|     longCovid: {\n00751|       name: 'Long COVID',\n00752|       fullName: 'Post-acute sequelae of SARS-CoV-2',\n00753|       icdCode: 'U09.9',\n00754|       criteria: [\n00755|         'COVID-19 infection history',\n00756|         'Symptoms ≥3 months duration',\n00757|         'Multi-system involvement',\n00758|         'Functional impairment'\n00759|       ]\n00760|     },\n00761|     pots: {\n00762|       name: 'POTS',\n00763|       fullName: 'Postural Orthostatic Tachycardia Syndrome',\n00764|       icdCode: 'I47.1',\n00765|       criteria: [\n00766|         'HR increase ≥30 bpm on standing',\n00767|         'Orthostatic symptoms',\n00768|         'Chronic duration ≥3 months',\n00769|         'No orthostatic hypotension'\n00770|       ]\n00771|     }\n00772|   },\n00773| \n00774|   navigation: {\n00775|     assessmentModules: 'Training Modules',\n00776|     guidelines: 'Guidelines',\n00777|     diagnosticTools: 'Educational Tools',\n00778|     clinicalGuidelines: 'Clinical Guidelines & References',\n00779|     guidelinesDescription: 'Evidence-based guidelines used in VisibleDx educational training modules',\n00780|     assessmentModulesSection: 'Training Modules',\n00781|     guidelinesSection: 'Guidelines & References',\n00782|     moreGuidelines: 'more guidelines',\n00783|     smartBadge: 'Smart'\n00784|   },\n00785| \n00786|   languages: {\n00787|     en: 'English',\n00788|     nl: 'Nederlands',\n00789|     da: 'Dansk'\n00790|   },\n00791| \n00792|   disclaimer: 'EDUCATIONAL TOOL ONLY - This open-source training tool is designed for healthcare education and training purposes only. It is NOT a medical device and must NOT be used for patient care, diagnosis, or treatment decisions. Always consult qualified medical professionals for patient care.',\n00793| \n00794|   footer: {\n00795|     about: {\n00796|       title: 'About VisibleDx',\n00797|       description: 'VisibleDx is an open-source educational training tool for learning about ME/CFS, Long COVID, and POTS criteria. Designed exclusively for healthcare education, training, and research purposes - NOT for patient care or medical use.',\n00798|       badges: {\n00799|         sensitivity: '94% Sensitivity',\n00800|         evidenceBased: 'Evidence-Based',\n00801|         openSource: 'Open Source'\n00802|       }\n00803|     },\n00804|     evidence: {\n00805|       title: 'Evidence Base',\n00806|       guidelines: [\n00807|         {\n00808|           title: 'CDC Diagnosing ME/CFS (2024)',\n00809|           url: 'https://www.cdc.gov/me-cfs/hcp/diagnosis/?CDC_AAref_Val=https://www.cdc.gov/me-cfs/healthcare-providers/diagnosis/index.html'\n00810|         },\n00811|         {\n00812|           title: 'NASEM ME/CFS Report (2015)',\n00813|           url: 'https://nap.nationalacademies.org/read/19012'\n00814|         },\n00815|         {\n00816|           title: 'WHO Long COVID Definition (2021)',\n00817|           url: 'https://www.who.int/publications/i/item/9789240025035'\n00818|         },\n00819|         {\n00820|           title: 'ESC POTS Guidelines (2018)',\n00821|           url: 'https://academic.oup.com/europace/article/20/6/921/4824690'\n00822|         },\n00823|         {\n00824|           title: 'AAS/EFAS POTS Consensus (2021)',\n00825|           url: 'https://link.springer.com/article/10.1007/s10286-021-00822-5'\n00826|         },\n00827|         {\n00828|           title: 'NASA Lean Stand Test Protocol',\n00829|           url: 'https://ntrs.nasa.gov/citations/20150021566'\n00830|         }\n00831|       ]\n00832|     },\n00833|     notes: {\n00834|       title: 'Important Notes',\n00835|       items: [\n00836|         'Training tool only - NOT for patient care',\n00837|         'Educational simulation - NOT real diagnosis',\n00838|         'Open-source software for learning purposes',\n00839|         'Must NOT replace medical professional judgment',\n00840|         'For healthcare education and research only',\n00841|         'Contact medical professionals for patient care'\n00842|       ]\n00843|     },\n00844|     bottom: {\n00845|       version: 'VisibleDx v1.0 - Educational Tool',\n00846|       copyright: '© 2024 VisibleDx',\n00847|       audienceLabel: 'For Healthcare Education Only',\n00848|       badge: 'Research & Education Use'\n00849|     },\n00850|     technical: 'Educational simulation based on peer-reviewed literature. Training data for educational purposes only. This tool is NOT validated for clinical use and must NOT be used for patient care or medical decisions.'\n00851|   },\n00852| \n00853|   ppgCamera: {\n00854|     title: 'Camera PPG Heart Rate',\n00855|     description: 'Place your fingertip gently over the camera lens with flashlight on',\n00856|     fingerDetected: 'Finger Detected',\n00857|     placeFingerPrompt: 'Place Finger',\n00858|     signalQuality: {\n00859|       poor: 'poor',\n00860|       fair: 'fair',\n00861|       good: 'good'\n00862|     },\n00863|     status: {\n00864|       stopped: 'stopped',\n00865|       starting: 'starting',\n00866|       detecting: 'detecting',\n00867|       measuring: 'measuring'\n00868|     },\n00869|     recordReading: 'Record Reading',\n00870|     instructions: {\n00871|       flashlight: 'Turn on your device\\'s flashlight',\n00872|       placement: 'Gently place fingertip over camera lens',\n00873|       stillness: 'Stay still and breathe normally',\n00874|       wait: 'Wait for stable reading (10+ seconds)'\n00875|     },\n00876|     errors: {\n00877|       cameraAccess: 'Camera access denied',\n00878|       noCamera: 'No camera available'\n00879|     }\n00880|   },\n00881| \n00882|   soapNotes: {\n00883|     clinician: 'Clinician',\n00884|     patientId: 'Patient ID',\n00885|     age: 'Age',\n00886|     gender: 'Gender',\n00887|     notSpecified: 'Not specified',\n00888|     notRecorded: 'Not recorded',\n00889|     pemPresent: 'Present',\n00890|     notPresent: 'Not present',\n00891|     baselineHR: 'Baseline HR',\n00892|     peakStandingHR: 'Peak Standing HR',\n00893|     hrIncrease: 'HR Increase',\n00894|     cannotCalculate: 'Cannot calculate',\n00895|     potsCriteriaMet: 'MET (≥30 bpm increase)',\n00896|     potsNotMet: 'Not met',\n00897|     severity: 'severity'\n00898|   }\n00899| }\n</file>",
    "metadata": {
      "preview": "import { Translation } from './types'\n\nexport const en: Translation = {\n  app: {\n    title: 'VisibleDx: ME/CFS · Long COVID · POTS',\n    subtitle: 'An educational training tool for learning evidence-based criteria for ME/CFS, Long COVID, and POTS. For healthcare education and training purposes only.',\n    tagline: 'Making invisible diseases visible - with evidence, empathy and code.',\n    backToDashboard: 'Back to Dashboard'\n  },\n\n  common: {\n    yes: 'Yes',\n    no: 'No',\n    next: 'Next',\n    previous: 'Previous',\n    continue: 'Continue',\n    complete: 'Complete',\n    cancel: 'Cancel',\n    save: 'Save',\n    download: 'Download',"
    },
    "title": "lib/translations/en.ts",
    "time": {
      "start": 1758180484034,
      "end": 1758180484037
    }
  }
}